- Home
- GH vs OSK Comparison
GH vs OSK Comparison
Compare GH & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- OSK
- Stock Information
- Founded
- GH 2011
- OSK 1917
- Country
- GH United States
- OSK United States
- Employees
- GH N/A
- OSK N/A
- Industry
- GH Medical Specialities
- OSK Auto Manufacturing
- Sector
- GH Health Care
- OSK Consumer Discretionary
- Exchange
- GH Nasdaq
- OSK Nasdaq
- Market Cap
- GH 4.9B
- OSK 5.6B
- IPO Year
- GH 2018
- OSK N/A
- Fundamental
- Price
- GH $50.00
- OSK $124.21
- Analyst Decision
- GH Strong Buy
- OSK Buy
- Analyst Count
- GH 20
- OSK 14
- Target Price
- GH $54.35
- OSK $123.14
- AVG Volume (30 Days)
- GH 2.1M
- OSK 876.4K
- Earning Date
- GH 08-06-2025
- OSK 08-01-2025
- Dividend Yield
- GH N/A
- OSK 1.64%
- EPS Growth
- GH N/A
- OSK N/A
- EPS
- GH N/A
- OSK 9.37
- Revenue
- GH $773,996,000.00
- OSK $10,499,200,000.00
- Revenue This Year
- GH $23.14
- OSK N/A
- Revenue Next Year
- GH $21.42
- OSK $5.73
- P/E Ratio
- GH N/A
- OSK $13.26
- Revenue Growth
- GH 28.20
- OSK 5.69
- 52 Week Low
- GH $20.14
- OSK $76.82
- 52 Week High
- GH $53.42
- OSK $124.67
- Technical
- Relative Strength Index (RSI)
- GH 60.59
- OSK 82.11
- Support Level
- GH $48.07
- OSK $108.89
- Resistance Level
- GH $53.42
- OSK $114.37
- Average True Range (ATR)
- GH 2.25
- OSK 2.55
- MACD
- GH -0.12
- OSK 0.87
- Stochastic Oscillator
- GH 55.56
- OSK 96.50
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About OSK Oshkosh Corporation (Holding Company)Common Stock
Oshkosh Corp is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms. The company had manufactured joint light tactical vehicles for the U.S. Department of Defense. The company reports in three segments: Access, Vocational and Defense. It derives maximum revenue from Access Segment.